Remove Health Inflammation
article thumbnail

Inflammation among current dementia research focus, says Alchemab CSO

Pharmaceutical Technology

Inflammation, cell metabolism and neuronal health are current key areas of focus for dementia researchers, according to Jane Osbourn, chief scientific officer (CSO) at Alchemab.

Research 246
article thumbnail

Abzena, Alira Health and Oncodesign launch DRIVE Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation

Pharma Mirror

The post Abzena, Alira Health and Oncodesign launch DRIVE Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation appeared first on Pharma Mirror Magazine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Inflammation markers associated with COVID-19 during pregnancy may signal adverse impacts to long-term infant health

Scienmag

BOSTON – New research results demonstrate how inflammation from a COVID-19 infection during pregnancy could potentially impact long-term infant health, including infant growth and brain development.

article thumbnail

Safety finding weighs on Pfizer's inflammation drug, and could spell trouble for others

Bio Pharma Dive

A large safety study found that patients given Pfizer's Xeljanz had health issues like major heart complications and cancer at a higher rate than those who got a different kind of anti-inflammation drug.

Drugs 343
article thumbnail

Exploring Periodontal Disease: Present Therapies, Emerging Treatments, and Beyond

Pharma Mirror

Untreated Periodontitis ultimately results in tooth loss, chronic inflammation, and pain. There are also a variety of systemic health effects linked to the disease which are even more detrimental. The post Exploring Periodontal Disease: Present Therapies, Emerging Treatments, and Beyond appeared first on Pharma Mirror Magazine.

130
130
article thumbnail

Tiziana Life Sciences plans to assess intranasal foralumab for long Covid

Pharmaceutical Technology

Long Covid is a health condition characterised by the continuation or development of new symptoms three months after an initial SARS-CoV-2 infection. Foralumab is a fully human anti-CD3 monoclonal antibody, which works by binding to the T-cell receptor and regulating T-cell function to reduce pulmonary inflammation.

article thumbnail

Multiple sclerosis discovery could end disease's chronic inflammation

Medical Xpress

University of Virginia Health neuroscientists have discovered a potential way to disrupt the chronic inflammation responsible for multiple sclerosis.

111
111